Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.47 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.47 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.47 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.47 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.47 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.47 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.47 |
| ▸ | HINT1 | P49773 | 2/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1061031 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL13462039 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL1120690 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL14144174 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL278167 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL25407962 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL13296251 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL3422978 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL4386265 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 | |
| SCHEMBL314536 | 0.85 | ALDH1A1 (0.68) | ALDH1A1LMNAMAPTTP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| WO-2024097262-A1 | CHEMOPROTEOMIC CAPTURE OF RNA BINDING ACTIVITY IN LIVING CELLS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2024-05-10 | — | — | WO | disclosed |
| EP-1947092-B1 | Method for producing nucleic acid base having perfluoroalkyl group | TOSOH CORP (JP) | 2015-04-15 | — | — | EP | disclosed |
| US-8362203-B2 | Non-natural peptides as models for the development of antibiotics | WAYNE STATE UNIVERSITY (US) | 2013-01-29 | — | — | US | disclosed |
| US-7884202-B2 | Nucleobases are perfluoroalkylated in a one step process with a perfluoroalkyl halide in the presence of a sulfoxide, a peroxide and an iron compound; useful as medicinal drugs, intermediates for medicinal drugs and agricultural chemicals | TOSOH CORPORATION (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20110021748-A1 | Non-Natural Peptides as Models for the Development of Antibiotics | WAYNE STATE UNIVERSITY (US) | 2011-01-27 | — | — | US | disclosed |
| US-20090124796-A1 | Nucleobase Having Perfluoroalkyl Group and Process for Producing the Same | TOSOH CORPORATION (JP) | 2009-05-14 | — | — | US | disclosed |
| EP-1947092-A1 | NUCLEIC ACID BASE HAVING PERFLUOROALKYL GROUP AND METHOD FOR PRODUCING THE SAME | Tosoh Corporation (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-6951932-B2 | Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines | KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC. (US) | 2005-10-04 | — | — | US | disclosed |
| US-20030199686-A1 | Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. | 2003-10-23 | — | — | US | disclosed |
| EP-0670845-B1 | PROCESS FOR THE PREPARATION OF FLUDARABINE PHOSPHATE FROM GUANOSINE | SCHERING AG (DE) | 1998-01-14 | — | — | EP | disclosed |
| US-5668270-A | Process for the preparation of fludarabine or fludarabine phosphate from guanosine | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-09-16 | — | — | US | disclosed |
| US-5602246-A | Process for the preparation of fludarabine or fludarabine phosphate from guanosine | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-02-11 | — | — | US | disclosed |
| EP-0664294-A1 | Production of nucleoside analogues | Reese, Colin (GB) | 1995-07-26 | — | — | EP | disclosed |
| US-5412088-A | 6-O-substituted guanosine derivatives | RUTGERS, THE STATE UNIVERSITY (US) | 1995-05-02 | — | — | US | disclosed |
| US-4689404-A | Production of cytosine nucleosides | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-08-25 | — | — | US | disclosed |
| EP-0193903-A2 | Production of cytosine nucleosides | Takeda Chemical Industries, Ltd. (JP) | 1986-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199686-A1 | Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines | AMPD2, ADAR, ADA | ALDH1A1 2143/4885LMNA 2588/4885MAPT 4862/4885 |
| US-20110021748-A1 | Non-Natural Peptides as Models for the Development of Antibiotics | MRPL21, SPOUT1, EMG1 | ALDH1A1 3405/4885LMNA 2736/4885MAPT 3463/4885 |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | ALDH1A1 1153/4885LMNA 240/4885MAPT 953/4885 |
| US-20090124796-A1 | Nucleobase Having Perfluoroalkyl Group and Process for Producing the Same | PFAS, FPGS, NUDT1 | ALDH1A1 2255/4885LMNA 2811/4885MAPT 4013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.